Mediterranean Diet and Inequality in Early Breast Cancer

Social determinants such as education, income, marital status, and social networks play a crucial role in cancer outcomes, including breast cancer. One potential influencing factor is diet, and the Mediterranean diet has been shown to benefit both the health and the microbiome. This raises the question: Does adherence to the Mediterranean diet impact the microbiome, quality of life, overall well-being, and outcomes in breast cancer patients undergoing (neo)adjuvant treatment, particularly among those with unfavorable socioeconomic determinants? The Mediterranean diet consists of plant foods

Trial Details

NCT ID
NCT07007169
Phase
PHASE2
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • The goal is daily consumption of a minimum of 30 grams of dietary fiber and weekly consumption of a minimum of 30 different plant foods; minimizing the amount of ultra-processed food.
  • Standard Diet
Locations (sample)
  • Sønderborg, Southern Denmark, Denmark|54.90896,9.78917
  • Esbjerg, Denmark|55.47028,8.45187
  • Vejle, Denmark|55.70927,9.5357

Key Eligibility Criteria

  • Signed written informed consent approved by the Ethical Review Board.
  • Histologically confirmed unilateral adenocarcinoma of the breast, stage I-III, candidates for neoadjuvant chemotherapy followed by curative surgery…
  • Good performance status (WHO performance status 0 or 1).
  • Willingness by the patient to undergo treatment and study-related procedures according to the protocol.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →